SOUTH SAN FRANCISCO - CERo Therapeutics Holdings, Inc. (NASDAQ:CERO), an immunotherapy company specializing in engineered T cell therapeutics, has announced a series of strategic moves aimed at ...
Sale will hasten march of global franchise circuit, but should also safeguard county finances despite divisive process ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback